PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹15,284 Cr | ₹14,925 Cr | ₹14,437 Cr | ₹12,717 Cr | ₹10,756 Cr |
What is the latest Total Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹15,284 Cr |
| Mar2024 | ₹14,925 Cr |
| Mar2023 | ₹14,437 Cr |
| Mar2022 | ₹12,717 Cr |
| Mar2021 | ₹10,756 Cr |
How is Total Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15,284 Cr | 2.41 | |
| Mar2024 | ₹14,925 Cr | 3.39 | |
| Mar2023 | ₹14,437 Cr | 13.52 | |
| Mar2022 | ₹12,717 Cr | 18.23 | |
| Mar2021 | ₹10,756 Cr | - | |
Compare Total Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,742.6 Cr | -4.6% | -11.8% | -33% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -4.6% |
-11.8% |
-33% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses